BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

about

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

Item

http://www.wikidata.org/entity/Q55512760

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

@en

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

@nl

type

Item

label

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

@en

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

@nl

prefLabel

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

@en

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.

@nl

P1476

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells

@en

P2093

Chantal Mathieu

http://www.w3.org/2001/XMLSchema#string

Hannelie Korf

http://www.w3.org/2001/XMLSchema#string

Nicole Rufo

http://www.w3.org/2001/XMLSchema#string

Patrizia Agostinis

http://www.w3.org/2001/XMLSchema#string

P2860

CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47

The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications

Tumor suppressor functions of BNIP3 and mitophagy

The ever-expanding role of HIF in tumour and stromal biology

Phagocytosis of apoptotic cells in homeostasis

Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

Nivolumab in previously untreated melanoma without BRAF mutation

P304

17631-17644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24815

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Abhishek D. Garg

Erminia Romano

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29707136

http://www.w3.org/2001/XMLSchema#string

P932

5915144

http://www.w3.org/2001/XMLSchema#string